EUR 13.06
(1.08%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -9.11 Million EUR | -250.4% |
2022 | 6.05 Million EUR | 56.15% |
2021 | 3.87 Million EUR | -87.85% |
2020 | 31.92 Million EUR | 319.46% |
2019 | 7.61 Million EUR | 272.92% |
2018 | -4.4 Million EUR | 89.44% |
2017 | -41.65 Million EUR | -270.45% |
2016 | 24.44 Million EUR | -60.06% |
2015 | 61.18 Million EUR | 151.87% |
2014 | 24.29 Million EUR | 692.83% |
2013 | -4.09 Million EUR | 29.34% |
2012 | -5.8 Million EUR | 93.11% |
2011 | -84.12 Million EUR | -1366.42% |
2010 | 6.64 Million EUR | 24.66% |
2009 | 5.32 Million EUR | 0.0% |
2008 | 5.32 Million EUR | -61.51% |
2007 | 13.84 Million EUR | -53.86% |
2006 | 30 Million EUR | 884.48% |
2005 | 3.04 Million EUR | -54.4% |
2004 | 6.68 Million EUR | 105.36% |
2003 | -124.68 Million EUR | -473.47% |
2002 | -21.74 Million EUR | 9.67% |
2001 | -24.06 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -10.3 Million EUR | 0.0% |
2023 FY | -9.11 Million EUR | -250.4% |
2023 Q4 | 18.15 Million EUR | 0.0% |
2023 Q2 | -27.26 Million EUR | 0.0% |
2022 Q4 | 7.77 Million EUR | 0.0% |
2022 Q2 | -1.71 Million EUR | 0.0% |
2022 FY | 6.05 Million EUR | 56.15% |
2021 Q4 | 5.81 Million EUR | 0.0% |
2021 FY | 3.87 Million EUR | -87.85% |
2021 Q2 | -1.93 Million EUR | 0.0% |
2020 Q2 | -12.04 Million EUR | 0.0% |
2020 Q4 | 43.96 Million EUR | 0.0% |
2020 FY | 31.92 Million EUR | 319.46% |
2019 FY | 7.61 Million EUR | 272.92% |
2019 Q2 | -5.31 Million EUR | 0.0% |
2019 Q4 | 12.92 Million EUR | 0.0% |
2018 Q2 | -7.67 Million EUR | 0.0% |
2018 FY | -4.4 Million EUR | 89.44% |
2017 FY | -41.65 Million EUR | -270.45% |
2017 Q2 | -4.63 Million EUR | 0.0% |
2016 Q4 | 16.19 Million EUR | 0.0% |
2016 FY | 24.44 Million EUR | -60.06% |
2016 Q2 | 8.34 Million EUR | 0.0% |
2015 Q2 | 14.49 Million EUR | 0.0% |
2015 Q4 | 46.77 Million EUR | 0.0% |
2015 FY | 61.18 Million EUR | 151.87% |
2014 Q2 | 3.75 Million EUR | 0.0% |
2014 FY | 24.29 Million EUR | 692.83% |
2013 Q4 | -5.89 Million EUR | 0.0% |
2013 FY | -4.09 Million EUR | 29.34% |
2013 Q2 | 1.79 Million EUR | 0.0% |
2012 FY | -5.8 Million EUR | 93.11% |
2012 Q4 | 744 Thousand EUR | 111.77% |
2012 Q3 | -6.31 Million EUR | 0.0% |
2012 Q2 | -6.31 Million EUR | 0.0% |
2012 Q1 | -6.31 Million EUR | 0.0% |
2011 Q2 | -4.43 Million EUR | 0.0% |
2011 Q4 | -6.31 Million EUR | -42.42% |
2011 FY | -84.12 Million EUR | -1366.42% |
2011 Q3 | -4.43 Million EUR | 0.0% |
2011 Q1 | -4.43 Million EUR | 0.0% |
2010 Q3 | 1.66 Million EUR | 0.0% |
2010 FY | 6.64 Million EUR | 24.66% |
2010 Q4 | -4.43 Million EUR | -367.2% |
2010 Q1 | 1.66 Million EUR | 0.0% |
2010 Q2 | 1.66 Million EUR | 0.0% |
2009 FY | 5.32 Million EUR | 0.0% |
2009 Q3 | 1.33 Million EUR | 0.0% |
2009 Q2 | 1.33 Million EUR | 0.0% |
2009 Q4 | 1.66 Million EUR | 24.66% |
2009 Q1 | 1.33 Million EUR | 0.0% |
2008 FY | 5.32 Million EUR | -61.51% |
2008 Q4 | 1.33 Million EUR | -71.79% |
2008 Q3 | 4.72 Million EUR | 0.0% |
2008 Q2 | 4.72 Million EUR | 0.0% |
2008 Q1 | 4.72 Million EUR | 0.0% |
2007 Q4 | 4.72 Million EUR | 15712.4% |
2007 FY | 13.84 Million EUR | -53.86% |
2007 Q1 | -30.25 Thousand EUR | 0.0% |
2007 Q2 | -30.25 Thousand EUR | 0.0% |
2007 Q3 | -30.25 Thousand EUR | 0.0% |
2006 FY | 30 Million EUR | 884.48% |
2006 Q4 | -30.25 Thousand EUR | -100.38% |
2006 Q2 | 7.87 Million EUR | 0.0% |
2006 Q1 | 7.87 Million EUR | 0.0% |
2006 Q3 | 7.87 Million EUR | 0.0% |
2005 Q2 | 680.75 Thousand EUR | 0.0% |
2005 Q3 | 680.75 Thousand EUR | 0.0% |
2005 FY | 3.04 Million EUR | -54.4% |
2005 Q4 | 7.87 Million EUR | 1057.29% |
2005 Q1 | 680.75 Thousand EUR | 0.0% |
2004 Q2 | 1.67 Million EUR | 0.0% |
2004 Q4 | 680.75 Thousand EUR | -59.26% |
2004 FY | 6.68 Million EUR | 105.36% |
2004 Q1 | 1.67 Million EUR | 0.0% |
2004 Q3 | 1.67 Million EUR | 0.0% |
2003 Q1 | -31.17 Million EUR | 0.0% |
2003 Q4 | 1.67 Million EUR | 105.36% |
2003 Q2 | -31.17 Million EUR | 0.0% |
2003 Q3 | -31.17 Million EUR | 0.0% |
2003 FY | -124.68 Million EUR | -473.47% |
2002 Q4 | -31.17 Million EUR | -473.47% |
2002 Q3 | -5.43 Million EUR | 0.0% |
2002 Q1 | -5.43 Million EUR | 0.0% |
2002 Q2 | -5.43 Million EUR | 0.0% |
2002 FY | -21.74 Million EUR | 9.67% |
2001 FY | -24.06 Million EUR | 0.0% |
2001 Q4 | -5.43 Million EUR | 9.67% |
2001 Q3 | -6.01 Million EUR | 0.0% |
2001 Q1 | -6.01 Million EUR | 0.0% |
2001 Q2 | -6.01 Million EUR | 0.0% |
2000 Q4 | -6.01 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Affluent Medical SA | -15.65 Million EUR | 41.8% |
Bluelinea Société Anonyme | -1.62 Million EUR | -462.346% |
Carmat SA | -53.86 Million EUR | 83.089% |
Diagnostic Medical Systems S.A. | -4.94 Million EUR | -84.189% |
Euromedis Groupe | 13.11 Million EUR | 169.487% |
Eurobio Scientific Société anonyme | 4.83 Million EUR | 288.418% |
Ikonisys S.A. | -2.26 Million EUR | -301.738% |
Implanet S.A. | -6.67 Million EUR | -36.459% |
Median Technologies SA | -22.98 Million EUR | 60.36% |
SpineGuard SA | -4.18 Million EUR | -117.765% |
Theraclion SA | -3.67 Million EUR | -147.891% |
Euroapi S.A. | -189.7 Million EUR | 95.198% |
Guerbet SA | 23.86 Million EUR | 138.171% |
Koninklijke Philips N.V. | -466 Million EUR | 98.045% |
Sequana Medical NV | -32.56 Million EUR | 72.024% |